Unmasking of coeliac disease on interferon treatment for hepatitis C

Internal Medicine Journal

Volumn 40, Issue 1, 2010, Pages 85-87

  Lim, E J ^a   Watson, K ^b  

^a Austin Hospital   (Germany)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; FERRITIN; FOLIC ACID; HEMOGLOBIN; INTERFERON; LOPERAMIDE; METRONIDAZOLE; PEGINTERFERON ALPHA; RIBAVIRIN;

ABDOMINAL PAIN; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANEMIA; ANTIVIRAL THERAPY; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOATING; CASE REPORT; CELIAC DISEASE; DIARRHEA; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG TOLERABILITY; FEMALE; FERRITIN BLOOD LEVEL; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; GASTROINTESTINAL ENDOSCOPY; GLUTEN FREE DIET; HEMOGLOBIN BLOOD LEVEL; HEPATITIS C; HISTOPATHOLOGY; HUMAN; INTESTINE BIOPSY; LETTER; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FUNCTION TEST; NAUSEA; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT RESPONSE; VOMITING;

CELIAC DISEASE; DIAGNOSIS, DIFFERENTIAL; DIET, GLUTEN-FREE; FEMALE; HEPATITIS C; HUMANS; INTERFERONS; MIDDLE AGED; TREATMENT OUTCOME;

EID: 76749149549     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2009.02087.x     Document Type: Letter

References (15)

1. Antonelli A, Ferri C, Pampana A, Fallahi P, Nesti C, Pasquini M et al. Thyroid disorders in chronic hepatitis C. Am J Med 2004 117 : 10.
2. Haddad J, Deny P, Munz-Gotheil C, Ambrosini JC, Trinchet JC, Pateron D et al. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992 339 : 321.
3. Fine KD, Ogunji F, Saloum Y, Beharry S, Crippin J, Weinstein J. Celiac sprue: another autoimmune syndrome associated with hepatitis C. Am J Gastroenterol 2001 96 : 138 145.
4. Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995 21 : 613.
5. Strader DB, Wright T, Thomas DL, Seef LB. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004 39 : 1147.
6. Tursi A. Rapid onset of ulcerative colitis after treatment with PEG-interferon plus ribavirin for chronic hepatitis C. Inflamm Bowel Dis 2007 13 : 1189 1190.
7. Harada H, Tamaoka A, Kohno Y, Mochizuki A, Shoji S. Exacerbation of myasthenia gravis in a patient after interferon-beta treatment for chronic active hepatitis C. J Neurol Sci 1999 165 : 182.
8. Georgetson MJ, Yarze JC, Lalos AT, Webster GF, Martin P. Exacerbation of psoriasis due to interferon-alpha treatment of chronic active hepatitis. Am J Gastroenterol 1993 88 : 1756.
9. Tahan V, Ozseker F, Guneylioglu D, Baran A, Ozaras R, Mert A et al. Sarcoidosis after use of interferon for chronic hepatitis C: report of a case and review of the literature. Dig Dis Sci 2003 48 : 169.
10. Durante-Mangoni E, Iardino P, Resse M, Cesaro G, Sica A, Farzati B et al. Silent celiac disease in chronic hepatitis C: impact of interferon treatment on the disease onset and clinical outcome. J Clin Gastroenterol 2004 38 : 901 905.
11. Vial T, Descotes J. Clinical toxicity of the interferons. Drug Saf 1994 10 : 115.
12. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL Jr. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002 347 : 975.
13. Bardella MT, Vecchi M, Conte D, Del Ninno E, Fraquelli M, Pacchetti S et al. Chronic unexplained hypertransaminasemia may be caused by occult celiac disease. Hepatology 1999 29 : 654 657.
14. Kaukinen K, Halme L, Collin P, Fkkilä M, Mäki M, Vehmanen P et al. Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure. Gastroenterology 2002 122 : 881 888.
15. Bourliere M, Oules V, Perrier H, Mengotti C. Onset of coeliac disease and interferon treatment. Lancet 2001 357 : 803 804.